Y Intercept (Hong Kong) LTD Zentalis Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.78 Billion
- Q2 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 103,916 shares of ZNTL stock, worth $294,082. This represents 0.02% of its overall portfolio holdings.
Number of Shares
103,916Holding current value
$294,082% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ZNTL
# of Institutions
148Shares Held
69.9MCall Options Held
61.8KPut Options Held
6.6K-
Matrix Capital Management Company, LP Waltham, MA14MShares$39.5 Million0.43% of portfolio
-
Eventide Asset Management, LLC Boston, MA8.55MShares$24.2 Million0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$13.6 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.5MShares$12.7 Million0.0% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $161M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...